Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 3Terminated 2Completed 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 2

Conditions

Neoplasms 1905Breast Neoplasms 1426Carcinoma, Non-Small-Cell Lung 1179Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 624Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Recurrence 374Lymphoma 374Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Advanced Malignant Neoplasm × Clear all
NCT05997342 2025-08-11

A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Completed
36 enrolled
Other neoplasm

Advanced Malignant Neoplasm

NCT06344351 2025-05-22

A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Completed
27 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡